|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 47/68 | |
| A61P 35/02 |
| (11) | Patento numeris | 2427216 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10718581.1 |
| Europos patento paraiškos padavimo data | 2010-05-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-03-14 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-02-20 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2010/056124 |
| Data | 2010-05-05 |
| (87) | Numeris | WO 2010/128087 |
| Data | 2010-11-11 |
| (30) | Numeris | Data | Šalis |
| 176069 P | 2009-05-06 | US | |
| 259430 P | 2009-11-09 | US |
| (72) |
OSTERROTH, Frank, DE
UHEREK, Christoph, DE
BRUECHER, Christoph, DE
DAELKEN, Benjamin, DE
ENGLING, André, DE
HAEDER, Thomas, DE
WARTENBERG-DEMAND, Andrea, DE
NIEMANN, Gabriele, DE
ZUBER, Chantal, DE
CZELOTH, Niklas, DE
AIGNER, Silke, DE
ZENG, Steffen, DE
SCHULZ, Gregor, DE
|
| (73) |
ImmunoGen, Inc.,
830 Winter Street, Waltham, MA 02451,
US
Biotest AG, Landsteinerstr. 5, 63303 Dreieich, DE |
| (54) | USES OF IMMUNOCONJUGATES TARGETING CD138 |
| USES OF IMMUNOCONJUGATES TARGETING CD138 |